Three-decade investment professional with experience in US public stocks, leveraged buyouts and venture capital. CEO of Cestrian Capital Research, Inc.
Market On Open, Wednesday 22 October
Pass The Tylenol, Marjorie
Invivyd - Company Review
$IVVD, A Speculative Play In Monoclonal Antibodies